AbbVie Inc. (ABBV) vs ExxonMobil Holdings Corp(XOM)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | ABBV | XOM |
|---|---|---|
| Sector | Health Care | Energy |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $61.16B | $332.24B |
| Revenue growth (YoY) | ▲ 8.6% | ▼ 5.0% |
| Net income | $4.23B | $29.76B |
| Gross margin | — | — |
| Diluted EPS | $2.36 | $6.70 |
| Insider net (6 mo) | −11.6K sh · 3 sells · 0 buys | −16.6M sh · 3 sells · 0 buys |
| Institutional owners | 46 | 47 |
| Institutional value held | $222.87B | $274.77B |
| Next earnings (est.) | Around Oct 30, 2026 | Oct 30, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About AbbVie Inc. (ABBV)
AbbVie Inc., incorporated in Delaware in 2012, is a global, diversified research-based biopharmaceutical company that became an independent, publicly-traded entity on January 1, 2013, following its spin-off from Abbott Laboratories.
About ExxonMobil Holdings Corp (XOM)
Exxon Mobil Corporation, operating under brands including ExxonMobil, Exxon, Esso, Mobil, and XTO, is a globally integrated energy and petrochemical company engaged in the exploration, production, manufacture, transport, and sale of crude oil, natural gas, pet
Source: SEC EDGAR.